Institutional investors purchased a net $2.9 million shares of ASMB during the quarter ended September 2017. This may signal that the smart money is gaining interest in this company as the 88.72% of the shares outstanding that institutional investors hold is among the lowest in the Pharmaceuticals: Other industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
VALEO FINANCIAL ADVISORS LLC Bought 3.2 Million shares of Assembly Biosciences Inc